Beam Therapeutics Inc. (BEAM) vs Intellia Therapeutics, Inc. (NTLA)
A side-by-side comparison of Beam Therapeutics Inc. and Intellia Therapeutics, Inc. across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 2, 2026. Differences are shown without an overall score or investment verdict.
BEAM
Beam Therapeutics Inc.
$24.47HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT
NTLA
Intellia Therapeutics, Inc.
$12.29HealthcareDelayed quote: Oct 2, 2026, 3:55 PM EDT
Total return — BEAM vs NTLA
growth of $100 · dividends reinvested · last 7yBEAM +30.1% (+3.8%/yr)NTLA -11.8% (-1.8%/yr)BEAM compounded faster over this window
BEAM NTLA
BEAM vs NTLA: by the numbers
- •BEAM is the larger company ($2.52B vs $1.72B market cap).
- •Both run net losses; BEAM's is the smaller (-54.75% vs -672.16% net margin).
- •BEAM grew revenue faster over the past five years (479.04% vs 7.31% CAGR).
Metrics side by side
Valuation
| Metric | BEAM | NTLA |
|---|---|---|
| P/S ratio | 16.13 | 28.85 |
| P/B ratio | 2.36 | 2.36 |
Profitability
| Metric | BEAM | NTLA |
|---|---|---|
| Gross margin | 84.05% | 76.47% |
| Operating margin | -274.57% | -651.67% |
| Net margin | -54.75% | -672.16% |
| ROE | -8.00% | -54.96% |
| ROIC | -28.96% | -54.45% |
Growth (annualized)
| Metric | BEAM | NTLA |
|---|---|---|
| Revenue CAGR (5Y) | 479.04% | 7.31% |
| Total return CAGR (5Y) | -22.35% | -38.17% |
Frequently asked
- Which has grown faster, BEAM or NTLA?
- Over the past five years, BEAM grew revenue faster — BEAM at a 479.04% CAGR versus NTLA at 7.31%.
- How have BEAM and NTLA total returns compared?
- Over the past 5 years, BEAM delivered -22.35% and NTLA delivered -38.17% annualized total return. Past performance doesn't predict future results.
Go deeper
Dig into the metrics
Beam Therapeutics ROEIntellia Therapeutics ROEBeam Therapeutics operating marginIntellia Therapeutics operating marginBeam Therapeutics revenue growthIntellia Therapeutics revenue growthBeam Therapeutics free cash flowIntellia Therapeutics free cash flow
Beam Therapeutics & Intellia Therapeutics appear in these rankings
Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 2, 2026.